Search
This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...
Peter Murphy advises domestic and international clients on a variety of corporate and commercial matters, including transactions and governance matters. Peter also leads the firm’s Corporate Transparency Act (CTA) Team, which guides domestic and foreign entities registered in the United States to...
Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...